fluticasone propionate (Flixotide)
What to know about fluticasone propionate — also sold as Flixotide, Fluticasone Cipla Inhaler, Axotide, Flixotide Accuhaler, Axotide Accuhaler and 4 more: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
fluticasone propionate (brand names: Flixotide, Fluticasone Cipla Inhaler, Axotide, Flixotide Accuhaler, Axotide Accuhaler and 4 more) is classified as Low risk (1 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. FDA approved in the United States. Inhaled corticosteroid with minimal systemic effects and work capacity impact.
Key Takeaways
- TGA Schedule: S4 in Australia
- Risk level: Low (1 points)
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S4 | PBS listed |
| United States (FDA) | Rx only | FDA approved |
Risk Profile
Inhaled corticosteroid with minimal systemic effects and work capacity impact.
How fluticasone propionate is regulated
fluticasone propionate is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Australia TGA / PBS / State Schemes
Classified as S4 under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
United States FDA / CDC / State WC
FDA approved for use in the United States.
Check this medication against your full medication list
Run a full risk assessment including fluticasone propionate interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.